Cancer development in cadaveric donor renal allograft recipients treated with azathioprine (AZA) or cyclosporine (CyA) or AZA/CyA

Transplant Proc. 1991 Feb;23(1 Pt 2):1111-2.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Azathioprine / adverse effects*
  • Cadaver
  • Cyclosporins / adverse effects*
  • Drug Therapy, Combination
  • Humans
  • Immunosuppression / adverse effects
  • Immunosuppression / methods
  • Kidney Transplantation / adverse effects*
  • Kidney Transplantation / methods
  • Neoplasms / etiology*
  • Risk Factors

Substances

  • Cyclosporins
  • Azathioprine